Immunohistochemical expression of TWIST in oral squamous cell carcinoma and its correlation with clinicopathologic factors
Author(s) -
Maryam Seyedmajidi,
Safoura Seifi,
Dariush Moslemi,
Seyyedeh-Fatemeh Mozaffari,
Hemmat Gholinia,
Zahra Zolfaghari
Publication year - 2018
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 1998-4138
pISSN - 0973-1482
DOI - 10.4103/0973-1482.224350
Subject(s) - immunohistochemistry , pathology , twist , carcinogenesis , epithelial–mesenchymal transition , medicine , metastasis , cancer , cell , cancer research , biology , geometry , genetics , mathematics
TWIST is a transcription factor that plays a key role in the development of primary tumor to metastatic stage of cancer. It is an inhibitor of E-cadherin in epithelial-to-mesenchymal transformation process (epithelial-mesenchymal transition). Few studies are available on the use of TWIST as a goal in molecular-targeted therapy. The aim of this study was to evaluate of TWIST expression in oral squamous cell carcinoma (OSCC) and its correlation with clinicopathologic factors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom